WO2003072128A8 - Procedes et composes destines a traiter des defauts osseux ou du cartilage - Google Patents

Procedes et composes destines a traiter des defauts osseux ou du cartilage

Info

Publication number
WO2003072128A8
WO2003072128A8 PCT/US2003/005200 US0305200W WO03072128A8 WO 2003072128 A8 WO2003072128 A8 WO 2003072128A8 US 0305200 W US0305200 W US 0305200W WO 03072128 A8 WO03072128 A8 WO 03072128A8
Authority
WO
WIPO (PCT)
Prior art keywords
defect
compositions
site
growth factors
methods
Prior art date
Application number
PCT/US2003/005200
Other languages
English (en)
Other versions
WO2003072128A3 (fr
WO2003072128A2 (fr
Inventor
Bruce Simon
Original Assignee
Ebi Lp
Bruce Simon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ebi Lp, Bruce Simon filed Critical Ebi Lp
Priority to AU2003219830A priority Critical patent/AU2003219830A1/en
Publication of WO2003072128A2 publication Critical patent/WO2003072128A2/fr
Publication of WO2003072128A3 publication Critical patent/WO2003072128A3/fr
Publication of WO2003072128A8 publication Critical patent/WO2003072128A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions et des procédés destinés à traiter des troubles et des défauts osseux et du cartilage qui consistent à appliquer des facteurs de croissance naturellement sécrétés au niveau du site de défaut. Plus spécifiquement, cette invention concerne un procédé de traitement d'un défaut osseux ou du cartilage consistant: à cultiver un tissu vivant, de manière que ce tissu sécrète plusieurs facteurs de croissance; et à administrer le facteur de croissance au site présentant le défaut. Les compositions de l'invention contiennent plusieurs facteurs de croissance humains sécrétés dans une culture par des tissus épidermiques vivants. De préférence, ces compositions contiennent aussi un excipient acceptable sur le plan pharmaceutique. Les facteurs de croissance sont libérés sur une matrice ou un milieu, puis traités en vue d'une introduction dans le site de défaut. Dans un mode de réalisation préféré, le milieu dans lequel les facteurs sont sécrétés est administré au site de défaut.
PCT/US2003/005200 2002-02-22 2003-02-21 Procedes et composes destines a traiter des defauts osseux ou du cartilage WO2003072128A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003219830A AU2003219830A1 (en) 2002-02-22 2003-02-21 Methods and compositions for treating bone or cartilage defects

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35877202P 2002-02-22 2002-02-22
US60/358,772 2002-02-22

Publications (3)

Publication Number Publication Date
WO2003072128A2 WO2003072128A2 (fr) 2003-09-04
WO2003072128A3 WO2003072128A3 (fr) 2003-12-31
WO2003072128A8 true WO2003072128A8 (fr) 2004-03-11

Family

ID=27765991

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/005200 WO2003072128A2 (fr) 2002-02-22 2003-02-21 Procedes et composes destines a traiter des defauts osseux ou du cartilage

Country Status (3)

Country Link
US (1) US20030180270A1 (fr)
AU (1) AU2003219830A1 (fr)
WO (1) WO2003072128A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148144A1 (en) * 2005-10-27 2007-06-28 Mason James M Gene-enhanced tissue engineering
EP1964583A1 (fr) 2007-02-09 2008-09-03 Royal College of Surgeons in Ireland Processus de production d'une base composite de collagène/hydroxyapatite
FR2948286B1 (fr) * 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
FR2954165B1 (fr) * 2009-12-18 2012-01-13 Jean-Noel Thorel Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
CA2018228C (fr) * 1989-06-05 1996-02-27 Nancy L. Parenteau Systemes et milieu de culture cellulaire
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
IL95429A (en) * 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
CA2080693C (fr) * 1990-04-24 2001-11-27 Mark Eisenberg Equivalents composites de peau vivante
US5891617A (en) * 1993-09-15 1999-04-06 Organogenesis Inc. Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing
US5599788A (en) * 1994-07-01 1997-02-04 Advanced Tissue Sciences Method for accelerating skin wound healing with H3 protein
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US6121042A (en) * 1995-04-27 2000-09-19 Advanced Tissue Sciences, Inc. Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs
US5792603A (en) * 1995-04-27 1998-08-11 Advanced Tissue Sciences, Inc. Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic or native, vascular grafts
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
ES2229277T3 (es) * 1995-06-07 2005-04-16 Organogenesis Inc. Composiciones de segmentos de fibra de colageno reconstituidos y metodos para su preparacion.
WO1996039992A1 (fr) * 1995-06-07 1996-12-19 Advanced Tissue Sciences, Inc. Appareil et procede pour steriliser, ensemencer, cultiver, stocker, expedier et tester des tissus cartilagineux de remplacement produits par assemblage
US5843766A (en) * 1995-06-07 1998-12-01 Advanced Tissue Sciences, Inc. Apparatus for the growth and packaging of three dimensional tissue cultures
MX9705540A (es) * 1996-01-30 1997-10-31 Organogenesis Inc Metodo y diseño de empaque para la crioconservacion y almacenamiento de equivalentes de tejido cultivado.
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5763267A (en) * 1996-04-16 1998-06-09 Advanced Tissue Sciences Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
AU3214797A (en) * 1996-05-28 1998-01-05 Regents Of The University Of Michigan, The Engineering oral tissues
US5718012A (en) * 1996-05-28 1998-02-17 Organogenesis, Inc. Method of strength enhancement of collagen constructs
US5993844A (en) * 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
JP4356053B2 (ja) * 1998-06-05 2009-11-04 オルガノジェネシス インク． 生物工学により作成した血管移植片支持体補綴
EP1203074A4 (fr) * 1999-06-29 2003-09-10 J Alexander Marchosky Compositions et procede de formation et de renforcement des os
US6673603B2 (en) * 2000-09-01 2004-01-06 Modex Therapeutiques, S.A. Cell paste comprising keratinocytes and fibroblasts

Also Published As

Publication number Publication date
AU2003219830A1 (en) 2003-09-09
WO2003072128A3 (fr) 2003-12-31
WO2003072128A2 (fr) 2003-09-04
US20030180270A1 (en) 2003-09-25
AU2003219830A8 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
Simon et al. Cambium cell stimulation from surgical release of the periosteum
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
ATE543509T1 (de) Material und verfahren zur förderung der reparatur von nervengewebe
SG152297A1 (en) Composition for stimulating bone growth and differentiation and method for isolating same
NO20052949L (no) Implantat inneholdende dyrkede bruksceller og fremgangsmate for fremstilling
ATE553186T1 (de) Bandscheibenreparatur und verfahren dafür
ATE395924T1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
SE9901973L (sv) Implantat för applicering i ben och förfarande och användning vid sådant implantat
SG146666A1 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
WO2005011569A3 (fr) Methodes comprenant l'utilisation de cellules derivees du tissu adipeux pour le transfert de graisse autologue a des fins d'augmentation
WO2003053362A3 (fr) Systemes et procedes permettant de traiter des patients avec un materiau riche en collagene extrait de tissus adipeux
WO2007062082A3 (fr) Methode et composition pour reparation et reconstruction de disques intervertebraux et autre chirurgie reconstructive
WO2005079822A3 (fr) Composition de cicatrisation
WO2003076604A3 (fr) Dispositif chirurgical destine a des therapies et a des tests cutanes
WO2003077833A3 (fr) Methode et appareil permettant de modifier l'activite de couches de tissus
RU2015153735A (ru) Гепарансульфаты
JP2012504598A (ja) 皮膚細胞の成長を促す方法、皮膚の状態又は頭髪の状態を治療する組成物
AU2003211140A8 (en) Composition and method for inducing bone growth and healing
WO2008006544A3 (fr) Utilisation de gélatine et d'un agent réticulant pour produire une composition thérapeutique à réticulation
WO2007056433A3 (fr) Procedes de traitement de defauts tissulaires
WO2004011631A3 (fr) Procedes et compositions pour traiter des anomalies tissulaires au moyen d'une excitation par champ electromagnetique pulse
Tan et al. Low-intensity pulsed ultrasound (LIPUS) and pulsed electromagnetic field (PEMF) treatments affect degeneration of cultured articular cartilage explants
NO20013744D0 (no) Fremgangsmåter og blandinger for heling og reparasjon av leddbrusk
WO2002092013A3 (fr) Methodes de traitement des maladies du foie et des lesions du foie a l'aide de l'hormone de croissance et de la proteine foxm1b
WO2003072128A8 (fr) Procedes et composes destines a traiter des defauts osseux ou du cartilage

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP